m+Medelevator.RU
← Поиск публикаций
Drug development and industrial pharmacy · 2026

Recent advances in cationic material integration for enhanced antimicrobial formulations.

СтатьяОбзорНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Salatin Sara, Ahmadi Shirin, Abedi Ghobadloo Parvin, Azarfarin Maryam, Hamidi Samin

Аннотация

OBJECTIVE: To review recent advances in cationic antimicrobial systems - including surfactants, polymers, peptides, quaternary ammonium-based materials, and ionic-liquid-derived agents - and to summarize emerging strategies aimed at combating antibiotic-resistant bacteria.

SIGNIFICANCE OF REVIEW: Cationic antimicrobial compounds provide a promising alternative to traditional antibiotics due to their membrane-disruptive action mediated by electrostatic interactions. This mechanism enables broad-spectrum activity while reducing the potential for resistance development.

KEY FINDINGS: A comprehensive evaluation of recent literature reveals substantial progress across multiple cationic antimicrobial platforms. Enhanced surfactants with improved membrane-disrupting efficiency, advanced cationic polymer architectures with greater biocompatibility, and engineered antimicrobial peptides (AMPs) with tunable properties have been reported. Furthermore, quaternary ammonium-based polymeric systems and rapidly expanding ionic-liquid antimicrobials demonstrate significant potential for diverse therapeutic and material applications.

CONCLUSIONS: Cationic antimicrobial agents are advancing through varied chemical designs and formulation strategies, offering effective tools against resistant bacterial strains. Continued innovation across surfactant, polymer, peptide, and ionic-liquid systems highlights their increasing promise for both clinical and industrial implementation.

Предметные рубрики MeSH

ИП Урсолов Владлен Сергеевич

ИНН 500118482352 · ОГРНИП 314500117700049

Реквизиты и контакты